Literature DB >> 15645755

Treatment of B-cell lymphoma with rituximab in two patients with Sjögren's syndrome associated with hepatitis C virus infection.

Manuel Ramos-Casals, Armando López-Guillermo, Pilar Brito-Zerón, Ricard Cervera, Josep Font.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15645755     DOI： 10.1191/0961203304lu2049xx

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  11 in total

1.  Consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Authors:  J S Smolen; E C Keystone; P Emery; F C Breedveld; N Betteridge; G R Burmester; M Dougados; G Ferraccioli; U Jaeger; L Klareskog; T K Kvien; E Martin-Mola; K Pavelka
Journal:  Ann Rheum Dis       Date:  2006-10-26       Impact factor: 19.103

Review 2.  Conventional therapy of Sjogren's syndrome.

Authors:  Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 3.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

4.  Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.

Authors:  Luca Quartuccio; Martina Fabris; Sara Salvin; Marta Maset; Ginevra De Marchi; Salvatore De Vita
Journal:  Int J Rheumatol       Date:  2010-01-28

5.  Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Authors:  Raphaèle Seror; Christelle Sordet; Loic Guillevin; Eric Hachulla; Charles Masson; Marc Ittah; Sophie Candon; Véronique Le Guern; Achille Aouba; Jean Sibilia; Jacques-Eric Gottenberg; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2006-09-01       Impact factor: 19.103

Review 6.  Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature.

Authors:  Juan C Rueda; Carolina Duarte-Rey; Nohemi Casas
Journal:  Rheumatol Int       Date:  2009-01-11       Impact factor: 2.631

Review 7.  Hepatitis C virus-related lymphoproliferative disorders: an overview.

Authors:  Anna-Linda Zignego; Carlo Giannini; Clodoveo Ferri
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

8.  'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.

Authors:  Massimo Marignani; Michela di Fonzo; Paola Begini; Elia Gigante; Ilaria Deli; Adriano M Pellicelli; Sara Gallina; Emanuela de Santis; Gianfranco Delle Fave; M Christina Cox
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

9.  Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection.

Authors:  Mahmoud Aboelneen Khattab; Mohammed Eslam; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

10.  Combined therapy with rituximab plus cyclophosphamide/vincristine/prednisone for Sjogren's syndrome-associated B-cell non-Hodgkin's lymphoma.

Authors:  J Carbone; R Perez-Fernandez; A Muñoz; P Sabin; L Carreño; E Fernandez-Cruz
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 10.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.